Buprenorphine/naloxone access for people with opioid use disorder in correctional facilities: taking steps to support knowledge translation

• Main Authors: Lori Regenstreif (Author), Marina Sadik (Author), Erin Beaulieu (Author), Claire Bodkin (Author), Lori Kiefer (Author), Dale Guenter (Author), Patsy W. P. Lee (Author), Fiona G. Kouyoumdjian (Author)
• Format: Book
• Published: BMC, 2022-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract People with opioid use disorders are overrepresented in correctional facilities, and are at high risk of opioid overdose. Despite the fact that buprenorphine/naloxone is the first line treatment for people with opioid use disorder, there are often institutional, clinical, and logistical bar...